About
Immuno-Oncology Nanodelivery
Areas of Focus
Categories
NanotechDrug Delivery & FormulationMidwest
Clinical Trials (39)
View allTotal Trials
39
As Lead Sponsor
31
As Collaborator
8
Total Enrollment
8,537
By Phase
EARLY_PHASE1: 1PHASE1: 11PHASE1/PHASE2: 3PHASE2: 11PHASE4: 6NA: 1PHASE2/PHASE3: 1PHASE3: 5
By Status
COMPLETED: 26WITHDRAWN: 5TERMINATED: 3UNKNOWN: 3NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline38 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT06656806Collaborator
Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety
EARLY_PHASE1Not yet recruiting
40 participants
Started: Dec 1, 2024 · Completed: May 1, 2025
NCT06182579Lead Sponsor
Phase I Study of RiMO-401 With Radiation in Advanced Tumors
PHASE1Terminated
5 participants
Started: Feb 22, 2024 · Completed: Jun 16, 2025
NCT05838729Lead Sponsor
Study of RiMO-301 and Radiotherapy With PD-1 Inhibitor for the Treatment of Head-Neck Cancer
PHASE1/PHASE2Recruiting
16 participants
Started: Apr 3, 2023 · Completed: Dec 31, 2026
NCT02153541Lead Sponsor
Assessing the Efficacy of CREWS01 to Decrease Usage of Rescue Inhalers in Moderate to Severe Asthmatic Adults
PHASE2Unknown
50 participants
Started: Apr 1, 2023 · Completed: Aug 1, 2023
NCT05484167Collaborator
Natesto Testosterone Nasal Gel for Hypogonadal Men
PHASE4Withdrawn
Started: Jan 1, 2023 · Completed: Apr 1, 2025
Funding History (1)
D
Sep 14, 2021
Locations (1)
Headquarters
Chicago, IL, United States
Map
Loading map...